| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/03/2009 | WO2008092281A8 Template-fixed peptidomimetics |
| 09/03/2009 | US20090221792 Microwave-Assisted Peptide Synthesis |
| 09/03/2009 | US20090221505 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| 09/03/2009 | US20090221482 Tissue protective peptides and uses thereof |
| 09/03/2009 | US20090221474 Histone deacetylases, and uses related thereto |
| 09/03/2009 | US20090220430 Fluorescent Imaging Agents |
| 09/03/2009 | CA2716650A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/02/2009 | EP2094721A1 Bis-sulfhydryl macrocyclization systems |
| 09/02/2009 | EP2094720A1 Selective inhibitors of neurotensin degrading enzymes |
| 09/02/2009 | EP1457498B9 Novel peptide having angiotensin convertase inhibitory effect |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | CN101519433A Insect allatostatin analogue modified by (substituted) phenylacrylic acid and application thereof in black beetle prevention |
| 09/02/2009 | CN101519432A Novel pentapeptide analogue and application thereof |
| 09/02/2009 | CN101519431A Peptide analogue juvenile hormone synthesis inhibitor containing phenylpropyl alcohol-glycerol-bright tripeptide fragment |
| 09/02/2009 | CN101519430A Novel juvenile hormone synthesis inhibitor-phenylpropyl alcohol-glycerol-bright tripeptide amide analogue |
| 09/02/2009 | CN101519429A Solid phase method for synchronizing Argatroban |
| 09/02/2009 | CN101519428A L-alanyl-L-glutamine compound and synthetic method thereof |
| 09/02/2009 | CN101519427A Peptide derivative with endothelin receptor antagonizing activity, drug composition and application thereof |
| 09/01/2009 | US7582728 Microwave-assisted peptide synthesis |
| 09/01/2009 | US7582725 Agents, which inhibit apoptosis in cells that are involved in wound healing |
| 09/01/2009 | US7582605 Phosphorus-containing hepatitis C serine protease inhibitors |
| 09/01/2009 | US7582604 Template-fixed peptidomimetics with antibacterial activity |
| 08/27/2009 | WO2009104741A1 Substrate for assaying β-glucan and/or endotoxin and assay method |
| 08/27/2009 | WO2009083663A3 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof |
| 08/27/2009 | WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds |
| 08/27/2009 | US20090215987 Peptide amidation process |
| 08/27/2009 | US20090215986 Solution Synthesis of Peptide Cell Growth Stimulators |
| 08/27/2009 | US20090215983 Compounds and methods for inhibiting hepatitis C virus replication |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215678 Preventing Vertical Endoparasite Infections |
| 08/27/2009 | US20090215665 Compositions and methods for promoting wound healing and tissue regeneration |
| 08/27/2009 | US20090215025 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 08/27/2009 | US20090214467 Methods of protecting against apoptosis using lipopeptides |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | CA2714853A1 Selective poly-n-substituted glycine antibiotics |
| 08/26/2009 | EP2093234A1 Oligopeptides for use as taste modulators |
| 08/26/2009 | EP2093208A2 Process for the preparation of 3,3-dimethylbutanal |
| 08/26/2009 | EP1625153B1 Acylated lysobactin-type nonadepsipeptides |
| 08/26/2009 | EP1624885A4 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1379698B1 Mobility-modified nucleobase polymers and methods of using same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101516904A Dimeric IAP antagonists |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579323 Analogs of hemiasterlin wherein the indole moiety of hemiasterlin has been deleted or replaced demonstrate potent anti-mitotic and cytotoxic activity; may be useful in treatment of colon, breast, lung cancers |
| 08/25/2009 | US7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 08/20/2009 | WO2009101178A1 Enzymatic conjugation of bioactive moieties |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/20/2009 | US20090209728 Peptides That Increase Collagen or Hyaluronic Acid Production |
| 08/20/2009 | US20090209472 Amide and peptide derivatives of dialkylenetriamines and their use as transfection agents |
| 08/20/2009 | US20090209041 Peptides and methods for inhibiting amyloid formation |
| 08/20/2009 | US20090208993 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 08/20/2009 | CA2714585A1 Enzymatic conjugation of bioactive moieties |
| 08/19/2009 | EP2090319A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 08/19/2009 | EP2089419A2 Inhibition of beta-amyloid aggregation |
| 08/19/2009 | EP2089418A2 Formation of organic nanostructure array |
| 08/19/2009 | EP2089417A2 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/19/2009 | EP2089416A1 Depsipeptides and their therapeutic use |
| 08/19/2009 | EP2089415A1 Depsipeptides and their therapeutic use |
| 08/19/2009 | EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 08/19/2009 | EP2089051A2 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 08/19/2009 | EP2089020A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/19/2009 | EP1824501B1 Protein hydrolysate with antidiabetic effect |
| 08/19/2009 | EP1463529B1 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 08/19/2009 | CN101511860A SMAC peptidomimetics useful as IAP inhibitors |
| 08/18/2009 | US7576175 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 08/18/2009 | US7576071 Antithrombotic compound |
| 08/18/2009 | US7576062 Compounds with growth hormone releasing properties |
| 08/18/2009 | US7576061 Methods for preventing mitochondrial permeability transition |
| 08/18/2009 | US7576056 Peptides and compounds that bind to a receptor |
| 08/18/2009 | CA2239282C Fused isoindolones as inhibitors of protein kinase c |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098016A1 Oligopeptides for use as taste modulators |
| 08/13/2009 | WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/13/2009 | WO2009007676A3 Biomolecule binding ligands |
| 08/13/2009 | WO2008071081A8 Preparation of low bleeding anticoagulant fusion protein and its use |
| 08/13/2009 | US20090203128 Nogo-Receptors and Methods of Use |
| 08/13/2009 | US20090202638 Bmp gene and fusion protein |
| 08/13/2009 | US20090202486 Difluorinated tripeptides as hcv serine protease inhibitors |
| 08/13/2009 | US20090202485 Heteroaryl-containing tripeptide hcv serine protease inhibitors |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/12/2009 | EP2088153A1 Crystal of glutathione and process for production thereof |
| 08/12/2009 | EP2088152A1 N'-{n-[3-oxo-lupen-28-oyl]-9-aminononanoyl}-3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent |
| 08/12/2009 | EP2086995A1 Hepatitis c virus inhibitors |
| 08/12/2009 | EP2086994A2 Inhibitors of hepatitis c virus |
| 08/12/2009 | EP2086993A1 Michael systems as transglutaminase inhibitors |
| 08/12/2009 | EP2086982A1 Hcv ns3 protease inhibitors |
| 08/12/2009 | EP2086980A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/12/2009 | EP2086967A2 Inhibitors of hepatitis c virus |
| 08/12/2009 | EP2086963A2 Hepatitis c virus inhibitors |
| 08/12/2009 | EP1924278A4 A kit of lyophilized thrombin and lyophilized fibrinogen used to compound fibrin membrane, and its application |
| 08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101506225A Cardioprotective compounds |
| 08/12/2009 | CN101506224A Peptide epoxyketones for proteasome inhibition |
| 08/12/2009 | CN101506223A 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 08/12/2009 | CN100526309C Dimeric compounds and their use as anti-viral agents |